Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation. [electronic resource]
Producer: 20150417Description: 1426-34 p. digitalISSN:- 1523-6536
- Acute Disease
- Cohort Studies
- Etanercept
- Female
- Glucocorticoids -- therapeutic use
- Graft vs Host Disease -- therapy
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Immunoglobulin G -- administration & dosage
- Male
- Middle Aged
- Prospective Studies
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Transplantation Conditioning -- adverse effects
- Transplantation, Homologous -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.